Ignite Creation Date:
2024-05-06 @ 7:49 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06149130
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2023-11-20
Brief Title:
Adebrelimab Combined With Dalpiciclib and Standard Endocrine Therapy for HRHER2 - Advanced Breast Cancer
Sponsor:
Tongji Hospital
Organization:
Tongji Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-11-20
First Submit QC Date:
November 20 2023
Study First Post Date:
2023-11-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-04-11
Last Update Post Date:
2024-04-15
Last Update Post Date Type:
ACTUAL